# EDGAR Filing Document

**Accession Number:** 0001186863
**File Stem:** 0001239819-23-000006
**Filing Date:** 2023-1
**Character Count:** 8506
**Document Hash:** c50cf7a8158d79ea34df85ff734f2872
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001239819-23-000006.hdr.sgml**: 20230104

**ACCESSION NUMBER**: 0001239819-23-000006

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230103

**FILED AS OF DATE**: 20230104

**DATE AS OF CHANGE**: 20230104

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** VITALE MARY BETH
- **CENTRAL INDEX KEY:** 0001186863

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-52008
- **FILM NUMBER:** 23507846

**MAIL ADDRESS:**
- **STREET 1:** 821 17TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LUNA INNOVATIONS INC
- **CENTRAL INDEX KEY:** 0001239819
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 301 FIRST STREET SW
- **STREET 2:** SUITE 200
- **CITY:** ROANOKE
- **STATE:** VA
- **ZIP:** 24011
- **BUSINESS PHONE:** 540-769-8400

**MAIL ADDRESS:**
- **STREET 1:** 301 FIRST STREET SW
- **STREET 2:** SUITE 200
- **CITY:** ROANOKE
- **STATE:** VA
- **ZIP:** 24011

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>VITALE MARY BETH<br><sub>(Last) (First) (Middle)</sub><br>C/O LUNA INNOVATIONS INCORPORATED<br>301 1ST STREET, SW, SUITE 200<br><sub>(Street)</sub><br>ROANOKE, VA 24011<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2023-01-03 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LUNA INNOVATIONS INC [ LUNA ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Units | <sup>(1)</sup> | 2023-01-03 |  | A |  | 1167.96<sup>(2)</sup> |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 1167.96 | $0 | 49476.89 | D |  |
| Stock Units | <sup>(1)</sup> | 2023-01-03 |  | A |  | 305.90<sup>(4)</sup> |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 305.9 | $0 | 49782.79 | D |  |
| Stock Units | <sup>(1)</sup> | 2023-01-03 |  | A |  | 139.04<sup>(5)</sup> |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 139.04 | $0 | 49921.83 | D |  |
| Stock Units | <sup>(1)</sup> | 2023-01-03 |  | A |  | 139.04<sup>(6)</sup> |  | <sup>(3)</sup> | <sup>(3)</sup> | Common Stock | 139.04 | $0 | 50060.87 | D |  |

---

### Footnotes:

(1) Stock Units are convertible into issuer's common stock on a 1-for-1 basis.

(2) This grant was made pursuant to the issuer's non-employee director compensation, as compensation for Ms. Vitale's service as a member of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $10,500.00 divided by $8.99, the closing price of the issuer's common stock on the Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.

(3) The stock units become issuable in common stock of the issuer at the election of the Reporting Person upon the earliest to occur of the Reporting Person's termination of service, a change in control of the issuer, an unforeseeable emergency, or a fixed date selected by the Reporting Person. The units have no expiration date.

(4) This grant was made pursuant to issuer's non-employee director compensation policy, as compensation for Ms. Vitale's service as the chair of the nominating and governance committee of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $2,750.00 divided by $8.99, the closing price of issuer's common stock on the Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.

(5) This grant was made pursuant to the issuer's non-employee director compensation policy, as compensation for Ms. Vitale's service on the audit committee of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $1,250.00 divided by $8.99, the closing price of issuer's common stock on Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.

(6) This grant was made pursuant to the issuer's non-employee director compensation policy, as compensation for Ms. Vitale's service on the risk committee of the board of directors for the period from January 1, 2023 to March 31, 2023. The number of restricted stock units is equal to $1,250.00 divided by $8.99, the closing price of issuer's common stock on Nasdaq Capital Market on January 3, 2023, the first trading day of the quarter. The Reporting Person elected to receive fees in stock units.

**Signature:** /s/ Scott A. Graeff, Attorney-In-Fact  
**Date:** 2023-01-04

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**